cognitive behavioral management of chemotherapy · pdf filecognitive behavioral management of...
Post on 07-Mar-2018
219 Views
Preview:
TRANSCRIPT
Cognitive Behavioral Cognitive Behavioral
Management of Management of
ChemotherapyChemotherapy--Related Related
Cognitive DysfunctionCognitive Dysfunction
Robert J. Ferguson, Ph.D.Robert J. Ferguson, Ph.D.
Eastern Maine Medical CenterEastern Maine Medical CenterUniversity of Maine Dept. of Psychology, University of Maine Dept. of Psychology,
Dartmouth Medical SchoolDartmouth Medical School
Janet Bayleran, PhDJanet Bayleran, PhD
Theresa White, CCRPTheresa White, CCRP
Sandra Sigmon, PhDSandra Sigmon, PhD
Sharon LaBrie, MSSharon LaBrie, MS
Merrill Garrett, MDMerrill Garrett, MD
Thomas Openshaw, MDThomas Openshaw, MD
Christine Fink, PhDChristine Fink, PhD
Shawn Ell, PhDShawn Ell, PhD
Tim Ahles, PhDTim Ahles, PhD
Paul Jacobsen, PhDPaul Jacobsen, PhD
Brenna McDonald, PsyD, Brenna McDonald, PsyD,
MBAMBA
••QuestionsQuestions
–– How to manage the problem?How to manage the problem?
––What are the proposed treatment What are the proposed treatment approaches?approaches?
••Behavioral/Cognitive BehavioralBehavioral/Cognitive Behavioral
••Rehabilitation Rehabilitation
••Pharmacological Pharmacological
Rehabilitation: Parallel Worlds?Rehabilitation: Parallel Worlds?
•• Compensatory Compensatory
Strategies:Strategies:–– Learning adaptive strategies Learning adaptive strategies
with retained cognitive skills with retained cognitive skills
and functional reand functional re--organization organization
of the brainof the brain
–– Enhance performance on Enhance performance on
everyday tasks that require everyday tasks that require
remembering (Rohling, et al., remembering (Rohling, et al.,
2010; Wilson, 2005)2010; Wilson, 2005)
•• Cognitive Cognitive Retraining:Retraining:–– Directly retrain cognitive Directly retrain cognitive
processes to promote processes to promote repair of damaged repair of damaged circuitry or development circuitry or development
of new circuitry with of new circuitry with repetitive practicerepetitive practice
(Rohling, et al., 2010; (Rohling, et al., 2010; Roberston & Murre, Roberston & Murre, 1999)1999)
Pine Street Foundation, Pine Street Foundation, Becoming Your Own Advocate NewsletterBecoming Your Own Advocate Newsletter, 2005., 2005.
Adjusted ZAdjusted Z--transformed domain scores for transformed domain scores for
chemotherapy vs. local therapy groups.chemotherapy vs. local therapy groups.
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
VerbalAbility
VerbalLearning
VerbalMemory*
VisualMemory
Psycho-motor*
Motor Attention/Correct
Attention/RT
BlockDesign
Neuropsychological Domain
Local Therapy
Chemotherapy
Normal neuropsych testingNormal neuropsych testing
scores? scores?
What Impairment?!What Impairment?!
www.huricanevoices.orgwww.huricanevoices.org
Employment function Employment function TannockTannock & Vardy, 2007& Vardy, 2007
www.huricanevoices.orgwww.huricanevoices.org
Home function Home function TannockTannock & Vardy, 2007& Vardy, 2007
Diathesis Stress ModelDiathesis Stress ModelNon-cancer Twin-Twin B
Chemotherapy-treated Twin-Twin A
3-back>0-back2-back>0-back1-back>0-back
Memory and Attention Memory and Attention Adaptation Training Adaptation Training
(MAAT):(MAAT):A Brief Behavioral Skills Program A Brief Behavioral Skills Program
for Cancer Survivors with for Cancer Survivors with Attention and Memory Problems Attention and Memory Problems Associated with ChemotherapyAssociated with Chemotherapy
Robert J. Ferguson, Ph.D.*Robert J. Ferguson, Ph.D.*Behavioral Medicine Section Behavioral Medicine Section Dartmouth Medical SchoolDartmouth Medical SchoolRUNNING HEAD: Memory and Attention TrainingRUNNING HEAD: Memory and Attention Training**This is not a published document. Please do not reproduce or diThis is not a published document. Please do not reproduce or distribute stribute without permission of the author.without permission of the author.
CognitiveCognitive--Behavioral Approach to Behavioral Approach to
Management of Cognitive Management of Cognitive
ProblemsProblems
•• Education and Education and ““memory failure memory failure
reattributionreattribution””
•• SelfSelf--awareness trainingawareness training
•• SelfSelf--regulation and stress managementregulation and stress management
•• Cognitive Compensatory strategiesCognitive Compensatory strategies
Brief CognitiveBrief Cognitive--Behavioral Treatment ScheduleBehavioral Treatment Schedule
VISIT CONTENT 1
• TREATMENT OVERVIEW & PROVISION OF BOOKLET • EDUCATION ON MEMORY AND ATTENTION AND EFFECTS OF
CHEMOTHERAPY • SELF-MONITORING INSTRUCTION • RELAXATION TRAINING • HOMEWORK
PHONE CONTACT 1
• REVIEW HOMEWORK, PROBLEM SOLVE
2
• HOMEWORK REVIEW • COMPENSATORY STRATEGY(IES) SELECTION, INSTRUCTION,
AND REHEARSAL • HOMEWORK
PHONE CONTACT 2
• REVIEW HOMEWORK, PROBLEM SOLVE
3
• HOMEWORK REVIEW • COMPENSATORY STRATEGY SELECTION, INSTRUCTION,
AND REHEARSAL • ACTIVITY PACING AND SCHEDULING • HOMEWORK • OVERVIEW
PHONE CONTACT 3
• REVIEW HOMEWORK, PROBLEM SOLVE
4
• HOMEWORK REVIEW • COMPENSATORY STRATEGY REVIEW • ACTIVITY PACING AND SCHEDULING REVIEW • PLAN FOR RELAPSE PREVENTION • WRAP-UP
MedicationsMedications
•• dexmethylphenidate (ddexmethylphenidate (d--MPH; Focalin)MPH; Focalin)–– N = 152 doubleN = 152 double--blind placebo controlblind placebo control
–– 27.7 mg/day, patients with various cancers (non27.7 mg/day, patients with various cancers (non--CNS; CNS; n = 77 dn = 77 d--MPH; 7 placebo) > 2 months postMPH; 7 placebo) > 2 months post--chemochemo
–– 8 weeks d8 weeks d--MPH or placeboMPH or placebo
–– Improvements in fatigue (FACITImprovements in fatigue (FACIT--Fatigue) Fatigue)
–– and memory (High Sensitivity Cog. Screen)and memory (High Sensitivity Cog. Screen)
–– 40.8% headaches; 27.6% nausea40.8% headaches; 27.6% nausea
(Lower, et al., 2005)(Lower, et al., 2005)
MedicationsMedications
•• modafinil (Provigil)modafinil (Provigil)–– N = 68 Breast cancer survivors doubleN = 68 Breast cancer survivors double--blind placebo blind placebo controlcontrol
–– 22.8 months after chemotherapy22.8 months after chemotherapy
–– Improvements in speed of memory, continuity of Improvements in speed of memory, continuity of attention, and quality of episodic secondary memory attention, and quality of episodic secondary memory on computerized neurocognitive measure vs. placebo on computerized neurocognitive measure vs. placebo
–– (Cognitive Drug Research computerized assessment)(Cognitive Drug Research computerized assessment)
(Kohli, et al., 2007)(Kohli, et al., 2007)
““Levels of EvidenceLevels of Evidence”” and CBT and CBT
DevelopmentDevelopment
1.1. OneOne--group pilot studygroup pilot study
2.2. Waitlist Control Waitlist Control RCTRCT (absolute efficacy)(absolute efficacy)
-- (No longer recommended, Herbert, 2003)(No longer recommended, Herbert, 2003)
3.3. RCT with active control conditionRCT with active control condition
4.4. Component AnalysisComponent Analysis
CognitiveCognitive--Behavioral Treatment of ChemotherapyBehavioral Treatment of Chemotherapy--
Related Attention and Memory Problems Among Related Attention and Memory Problems Among
Breast Cancer Survivors: A Pilot StudyBreast Cancer Survivors: A Pilot StudyPI: Ferguson, R. J. CoPI: Ferguson, R. J. Co-- PI: PI: Ahles, T.A. Ahles, T.A.
NCI: 1 R03 CA090151NCI: 1 R03 CA090151--02; Lance Armstrong Foundation02; Lance Armstrong Foundation
•• One group pilot design (feasibility, satisfaction)One group pilot design (feasibility, satisfaction)
•• Baseline, postBaseline, post--treatment, 2treatment, 2--month followmonth follow--upup
•• N = 29, Stage I, II BCA, no CNS tx, intrathecal tx, or N = 29, Stage I, II BCA, no CNS tx, intrathecal tx, or psychiatric, substance abuse, neurologic psychiatric, substance abuse, neurologic
•• Mean Age = 56 (7.81), mean IQ, est: 112.82, 15 yrs eduMean Age = 56 (7.81), mean IQ, est: 112.82, 15 yrs edu
•• YearsYears--post chemotherapy: 8.2 (4.4)post chemotherapy: 8.2 (4.4)
•• OUTCOMES:OUTCOMES:–– Improved Multiple Abilities SelfImproved Multiple Abilities Self--report Questionnaire (MASQ)report Questionnaire (MASQ)
–– Improved CVLTImproved CVLT--II Total Score (54, 55, 61, 59)II Total Score (54, 55, 61, 59)
–– Digit Symbol, Stroop, TrailDigit Symbol, Stroop, Trail--making improvementsmaking improvements
–– High Satisfaction 7.14 (1.09) 0High Satisfaction 7.14 (1.09) 0--8 rating8 rating
““Behavioral Management of Cognitive Behavioral Management of Cognitive Impairment Associated with Impairment Associated with ChemotherapyChemotherapy””
Lance Armstrong FoundationLance Armstrong FoundationR. Ferguson, PIR. Ferguson, PI
INCLUSIONINCLUSION
•• diagnosis of stage I and II breast cancer; diagnosis of stage I and II breast cancer;
•• at least 18 months postat least 18 months post--treatment currently disease free (not treatment currently disease free (not excluding individuals on hormonal therapies such as selective excluding individuals on hormonal therapies such as selective estrogen receptor modulators); estrogen receptor modulators);
•• treatment involved standard dose adjuvant chemotherapy; treatment involved standard dose adjuvant chemotherapy;
•• complaint of memory and attention following chemotherapy; complaint of memory and attention following chemotherapy;
•• able to speak read English;able to speak read English;
•• at least 18 years of age at diagnosis and able to provide informat least 18 years of age at diagnosis and able to provide informed ed written consent. written consent.
EXCLUSIONEXCLUSION
•• history of CNS disease; history of CNS disease;
•• history of CNS radiation, intrathecal therapy or CNShistory of CNS radiation, intrathecal therapy or CNS--involved involved surgery; surgery;
•• neuroneuro--behavioral risk factors such as traumatic brain injury, history behavioral risk factors such as traumatic brain injury, history of neurological disorder, learning disability or substance addicof neurological disorder, learning disability or substance addiction; tion;
•• current psychiatric disorder. current psychiatric disorder.
Outcome MeasuresOutcome Measures•• Multiple Abilities SelfMultiple Abilities Self--Report Questionnaire (MASQ)Report Questionnaire (MASQ)(Seidenberg, Haltiner, Taylor, Hermann, & Wyler, 1994)(Seidenberg, Haltiner, Taylor, Hermann, & Wyler, 1994)
–– 48 items, 5 pt Likert scale, almost always/never48 items, 5 pt Likert scale, almost always/never
–– Language, visualLanguage, visual--perceptual, visual memory, attention, verbal perceptual, visual memory, attention, verbal memorymemory
•• Quality of LifeQuality of Life--Cancer Survivor Scale (QOLCancer Survivor Scale (QOL--CS)CS)(Ferrell, Dow, & Grant, 1995)(Ferrell, Dow, & Grant, 1995)
–– 41 items, physical, psychological, social, spiritual scales41 items, physical, psychological, social, spiritual scales
–– 00--10 Likert scale10 Likert scale
•• CESCES--DD--StateState--Trait AnxietyTrait Anxiety
Outcome MeasuresOutcome Measures
SatisfactionSatisfaction
•• General (0 = not at all satisfied; 8 = completely General (0 = not at all satisfied; 8 = completely
satisfied)satisfied)
•• Improving Improving or helping to or helping to compensate forcompensate for
problems of memory and attention (0 = not at all problems of memory and attention (0 = not at all
helpful; 8 = completely helpful)helpful; 8 = completely helpful)
Outcome MeasuresOutcome MeasuresNeuropsychological Neuropsychological
Verbal DomainVerbal Domain
CVLTCVLT--2 Total Score2 Total Score
Processing SpeedProcessing Speed
Trail Making NumberTrail Making Number--Letter SwitchingLetter Switching
Stroop ColorStroop Color--Word Word
Stroop ColorStroop Color--Word SwitchingWord Switching
Digit SymbolDigit Symbol
SatisfactionSatisfaction
•• Mean General Satisfaction ratingMean General Satisfaction rating
–– 7.0 (7.0 (SD SD = 1.05; 0 = not at all satisfied; 8 = completely = 1.05; 0 = not at all satisfied; 8 = completely
satisfied)satisfied)
–– compensatingcompensating for daily memory failures for daily memory failures
((MM = 6.7; = 6.7; SDSD = 1.54)= 1.54)
–– improvingimproving memory (memory (MM = 5.2; = 5.2; SDSD = 1.59) = 1.59)
( 0 = not at all helpful; 8 = completely helpful) ( 0 = not at all helpful; 8 = completely helpful)
5 Top5 Top--rated strategies included:rated strategies included:0 = Not at all helpful; 4 = Completely helpful0 = Not at all helpful; 4 = Completely helpful
1.1. applied relaxation methods (selfapplied relaxation methods (self--regulation, regulation,
arousal reduction) arousal reduction) 3.63.6
2.2. using a schedule or day planner/organizerusing a schedule or day planner/organizer
3.3. verbal rehearsal methodsverbal rehearsal methods
4.4. activity pacing and scheduling activity pacing and scheduling
5.5. selfself--instructional traininginstructional training 3.03.0
ConclusionsConclusions
and Limitationsand Limitations
•• It appears that MAAT (CBT) may be effective It appears that MAAT (CBT) may be effective
to help improve to help improve coping and selfcoping and self--managementmanagement
of chemotherapy cognitive changeof chemotherapy cognitive change
•• Some evidence of verbal recall improvementSome evidence of verbal recall improvement
•• Participants are satisfiedParticipants are satisfied
•• Effect sizes are comparable, if not larger, than Effect sizes are comparable, if not larger, than
many cognitive rehabilitation interventions many cognitive rehabilitation interventions
(fair comparison?)(fair comparison?)
ConclusionsConclusions
and Limitationsand Limitations
•• The study was small, underpowered and The study was small, underpowered and
required linear interpolationrequired linear interpolation
•• No active treatment controlNo active treatment control
•• One clinician completed all treatment (RF)One clinician completed all treatment (RF)
•• More precise outcome measures: More precise outcome measures:
–– Improved measures of QOL impact: FACTImproved measures of QOL impact: FACT--Cog; Cog;
MIAMIA--AnxietyAnxiety
–– neuropsychological measures, secondaryneuropsychological measures, secondary
–– Memory selfMemory self--efficacy?efficacy?
Treatment Summary
Brief
Educational,
group format,
practice,
mastery
experience
More
research
needed
May not
improve
verbal
memory NP
performance
Visual-motor
speed (brief
visuospatial
memory test)
Daily
cognitive
complaints
Memory Self-
efficacy
Older adults
Mean age 82
11 cancer
survivors,
8 women;
3men
84 years
12Group CBT, face
to face
Eight 90-minute
visits
Compensatory
4 components:
1. Stress inoc.
2. Health Prmtn
3. Self-efficacy
4. Strategy trng
CBMEM
Cognitive
Behavioral
Model of
Everyday
Memory
(McDougall, et
al., 2011)
Pros & ConsTargeted
Outcomes
PopulationHours of
Contact
Type/FormatIntervention
Name
Treatment Summary
Longer but
Home-based
Does not
require visits
Does improve
auditory
processing
speed, likely
verbal-
auditory NP
performance
May not fully
generalize to
real world
application (?)
Adverse
events,
headache,
pain (34 of
487-7%)
RBANS
auditory
memory,
Processing
speed
.87
Overall
memory .30
Word list
delayed recall
.20
Older adults
Mean Age
75.3 (6.45)
40 Self-
administered,
Computer-based
40, 1-hour
sessions (5d/wk;
8wks),
Training (85%
adjusted
performance)
4 of 6 exercises
per session
Auditory
processing
speed training
(Cognitive
Stimulation)
Brain Fitness
Program, Posit
Science
(IMPACT
study)
Exp. Tx (ET)
Active Cont.
(AC)—
educational
DVD w/
quizzes
No Contact
cont. (NCC)
Pros & ConsTargeted
Outcomes
PopulationHours of
Contact
Type/FormatIntervention
Name
Future DirectionsFuture Directions
•• Increase MAAT Increase MAAT ““dosingdosing”” 8 visits8 visits
•• An active treatment RCT is needed with larger numbers and An active treatment RCT is needed with larger numbers and multiple cliniciansmultiple clinicians–– MAAT vs. Supportive Psychotherapy (Borkovec) or POSITMAAT vs. Supportive Psychotherapy (Borkovec) or POSIT--Science Science
•• FACTFACT--Cog (QOL impact), MIACog (QOL impact), MIA--A as the principal outcomesA as the principal outcomes–– This will also aid inclusion criteria This will also aid inclusion criteria
•• MAAT MAAT –– electronic? on line, Ielectronic? on line, I--phone based, Video conferencephone based, Video conference
•• Applied to Applied to –––– Other cancer treatments that contribute to cognitive impairmentOther cancer treatments that contribute to cognitive impairment
–– CNS diseaseCNS disease--related cognitive impairmentrelated cognitive impairment
–– MTBIMTBI
When in doubt, more cowbellWhen in doubt, more cowbell
top related